NASDAQ · Biotechnology

SLDB (SLDB) Stock

$7.89 +0.77% NASDAQ: SLDB Healthcare

Valuation

MetricValue
Price$7.89
Market Cap$776.77M
P/E Ratio-3.66
P/B Ratio1.89
P/S Ratio0.00
EPS (TTM)$-1.69
52-Week High$11.39
52-Week Low$3.79
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-57.37%
ROA-32.03%
ROCE-99.44%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.06
Current Ratio6.21

Annual Financials (USD)

Metric20212022202320242025
Revenue$14.0M$8.0M$0$0$0
Operating Profit$-72.0M$-106.0M$-104.0M$-130.0M$-179.0M
Net Profit$-72.0M$-86.0M$-96.0M$-125.0M$-174.0M
EPS$-10.14$-10.10$-4.83$-3.06$-1.99
Op Margin-530.5%-1315.2%———

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$232.0M$260.0M$165.0M$189.0M$233.0M
Total Liabilities$24.0M$49.0M$38.0M$51.0M$53.0M
Cash$119.0M$155.0M$74.0M$80.0M$60.0M
Borrowings$2.0M$29.0M$26.0M$24.0M$21.0M

Latest News

Does Solid Biosciences' (SLDB) Russell Growth Index Debut Reveal a Shift in Its Investor Base? Simply Wall St. · Jul 2, 2026 Sarepta's Elevidys Showing Signs of Stabilization as siRNA Pipeline Gains Importance, RBC Says MT Newswires · Jun 18, 2026 BioGene Therapeutics Inc. Appoints Ty Howton to Board of Directors TMX Newsfile · Jun 8, 2026 Solid Biosciences and NanoMosaic Announce Co-Marketing Agreement to Advance Gene Therapy Delivery and Analytics PR Newswire · Jun 2, 2026 Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire · Jun 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-78.0M$-98.0M$-94.0M$-100.0M$-156.0M
Investing Cash Flow$-92.0M$56.0M$8.0M$-17.0M$-60.0M
Financing Cash Flow$0$0$0$-4.0M$0
Net Cash Flow$-34.0M$36.0M$-81.0M$6.0M$-20.0M
Free Cash Flow$-79.0M$-101.0M$-96.0M$-101.0M$-157.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-1.76
FCF Yield-30.95%
Quick Ratio13.10
Interest Coverage—
Return 1Y18.05%
Return 3Y76.55%
Return 5Y-78.74%

Ownership

Insiders Held0.74%
Institutions Held104.73%
Institutions Float Held105.50%
Institutional HolderSharesReport Date
Perceptive Advisors Llc11,906,6462026-03-31
Bain Capital Life Sciences Investors, LLC9,808,8192026-03-31
RA Capital Management, L.P.9,339,9782026-03-31
Siren, L.L.C.7,690,4052026-03-31
Vestal Point Capital, LP5,000,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANNX $5.37 +0.75% -3.71 $879.83M 0.00%
AURA $7.06 -1.40% -4.35 $453.25M 0.00%
AUTLAutolus Therapeutics plc $1.46 -13.61% -1.35 — 0.00%
BNTC $13.07 -0.46% -11.78 $449.01M 0.00%
DSGN $13.57 +2.80% -11.56 $847.54M 0.00%

About SLDB

SLDB is led by CEO Alexander G. Cumbo, employs 100 people, headquartered in US, publicly traded since 2018.

SLDB stock trades at $7.89 with a market capitalization of $776.77M. The stock is valued at a price-to-earnings (P/E) ratio of -3.66, price-to-book of 1.89, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $3.79 and $11.39, and currently trades 30.7% below its 52-week high.

On profitability, SLDB generates a return on equity (ROE) of -57.37%, return on capital employed of -99.44%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides